Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Apr 1;37(4):857-869.e9.
doi: 10.1016/j.cmet.2025.01.024. Epub 2025 Feb 17.

Ergothioneine controls mitochondrial function and exercise performance via direct activation of MPST

Affiliations

Ergothioneine controls mitochondrial function and exercise performance via direct activation of MPST

Hans-Georg Sprenger et al. Cell Metab. .

Abstract

Ergothioneine (EGT) is a diet-derived, atypical amino acid that accumulates to high levels in human tissues. Reduced EGT levels have been linked to age-related disorders, including neurodegenerative and cardiovascular diseases, while EGT supplementation is protective in a broad range of disease and aging models. Despite these promising data, the direct and physiologically relevant molecular target of EGT has remained elusive. Here, we use a systematic approach to identify how mitochondria remodel their metabolome in response to exercise training. From these data, we find that EGT accumulates in muscle mitochondria upon exercise training. Proteome-wide thermal stability studies identify 3-mercaptopyruvate sulfurtransferase (MPST) as a direct molecular target of EGT; EGT binds to and activates MPST, thereby boosting mitochondrial respiration and exercise training performance in mice. Together, these data identify the first physiologically relevant EGT target and establish the EGT-MPST axis as a molecular mechanism for regulating mitochondrial function and exercise performance.

Keywords: MPST; ergothioneine; exercise; mitochondria.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests B.M.S. is a founder of Aevum Therapeutics, which is developing exercise-regulated molecules for therapeutic purposes. E.T.C. is a co-founder, equity holder, and board member of Matchpoint Therapeutics and a co-founder and equity holder in Aevum Therapeutics.

Update of

LinkOut - more resources